Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Services Research & Development

Go to the ORD website
Go to the QUERI website

HSR&D Citation Abstract

Search | Search by Center | Search by Source | Keywords in Title

Etiology and outcomes of veterans with spinal cord injury and disorders hospitalized with community-acquired pneumonia.

Chang HT, Evans CT, Weaver FM, Burns SP, Parada JP. Etiology and outcomes of veterans with spinal cord injury and disorders hospitalized with community-acquired pneumonia. Archives of physical medicine and rehabilitation. 2005 Feb 1; 86(2):262-7.

Related HSR&D Project(s)

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

If you have VA-Intranet access, click here for more information vaww.hsrd.research.va.gov/dimensions/

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.
   Search Dimensions for VA for this citation
* Don't have VA-internal network access or a VA email address? Try searching the free-to-the-public version of Dimensions



Abstract:

OBJECTIVE: To determine whether documentation of a causative organism for community-acquired pneumonia (CAP) is associated with outcomes, including mortality and length of stay (LOS), in hospitalized veterans with spinal cord injuries and disorders (SCIandD). DESIGN: Retrospective cohort study. SETTING: Patients with SCIandD admitted with CAP to any Veterans Affairs medical center between September 1998 and October 2000. PARTICIPANTS: Hospital administrative data on 260 patients with SCIandD and a CAP diagnosis. INTERVENTIONS: Not applicable. MAIN OUTCOMES MEASURES: All-cause, 30-day mortality and hospital LOS. RESULTS: An organism was documented by International Classification of Diseases, 9th Revision , discharge codes in 24% of cases. Streptococcus pneumoniae and Pseudomonas aeruginosa accounted for 32% and 21%, respectively, of the identified bacterial pathogens. The overall mortality rate was 8.5%. No significant association was found between etiologic diagnosis of CAP and 30-day mortality. Lower mortality was associated with treatment at a designated SCI center (relative risk = .35; confidence interval, .12-.99). Pathogen-based CAP diagnosis was significantly associated with longer LOS (adjusted r 2 = .023, P = .024). CONCLUSIONS: There was no association between etiologic diagnosis of CAP and 30-day mortality among people with SCIandD. Documentation of CAP etiology was associated with the variance in LOS. Pneumococcal vaccination and antibiotic therapy with antipseudomonal activity may be particularly prudent in these patients given the high frequency of these pathogens among SCIandD patients with CAP.





Questions about the HSR&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.